Fredrickson David Paul bought CAI
February 26, 2026 · Form 4 insider transaction
Fredrickson David Paul bought 2,492 shares of Caris Life Sciences, Inc. at $20.06 per share, a transaction worth $50.0K. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
2,492
Price
$20.06
Total value
$50.0K
InsiderFredrickson David Paul
Role—
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateFebruary 26, 2026
Filing dateFebruary 27, 2026
Shares owned after18,621
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Shares issued in lieu of cash compensation for 2025 board retainer fees. Number of shares determined by dividing the cash retainer earned by the ten trading day average of the daily volume weighted average price per share through and including February 25, 2026.